Aktuelle Position: Home > Wörterbuch 1> 10,16-Docosadienoicacid,11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-,(4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-

10,16-Docosadienoicacid,11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-,(4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-

Produktsname: 10,16-Docosadienoicacid,11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-,(4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-
CAS Registry Number: 56092-81-0
Synonyme: 10,16-Docosadienoic acid,11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[octahydro-5'-(1-hydroxyethyl)-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-,[2S-[2a[2'S*,5'R*(S*)],5b(4S*,6R*,8R*,10Z,12S*,14S*,16E,18S*,19S*,20R*,21R*)]]-;SQ 23377;Ionomycin;10,16-Docosadienoicacid,11,19,21-trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[(2S,2'R,5S,5'S)-octahydro-5'-[(1R)-1-hydroxyethyl]-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-,(4R,6S,8S,10Z,12R,14R,16E,18R,19R,20S,21S)-; [2S-[2a[2'S*,5'R*(S*)],5b(4S*,6R*,8R*,10Z,12S*,14S*,16E,18S*,19S*,20R*,21R*)]]-11,19,21-Trihydroxy-4,6,8,12,14,18,20-heptamethyl-22-[octahydro-5'-(1-hydroxyethyl)-2,5'-dimethyl[2,2'-bifuran]-5-yl]-9-oxo-10,16-docosadienoicacid;
Molecular Structure:
Molecular Formula: C41H72 O9
Molecular Weight: 709.005
Dichte:  1.072 g/cm3
Boiling Point:  817.2 °C at 760 mmHg
Brechungsindex:  1.512
Risiko-Codes:  22
S-Sätze:  36
Gefahrensymbole:  Xn: Harmful;

Andere Produkt